Highly specific monoclonal antibody which can detect CD45RO, differentiating between subpopulations of T lymphocytes.
| Inventor | Institute |
|---|---|
| Peter Beverley | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| Cat. #: | 151173 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell biology;Immunology;Tags and cell markers |
| Application: | FACS ; IHC ; IP ; WB |
| Target: | Protein tyrosine phosphatase, receptor type, C (PTPRC, CD45RO) |
| Reactivity: | Human |
| Clone: | UCH-L1 |
| Host: | Mouse |
| Class: | Monoclonal |
| Alternate name: | Protein Tyrosine Phosphatase; Receptor Type C; CD45 Antigen; CD45; L-CA; T2; Protein Tyrosine Phosphatase; Receptor Type; C Polypeptide; T2 Leukocyte Common Antigen; T2 Glycoprotein; EC 3.1.3.48; GP18; CD45R; B22; LCA; LY5 |
|---|---|
| Product description: | Highly specific monoclonal antibody which can detect CD45RO, differentiating between subpopulations of T lymphocytes. |
| Conjugation: | Unconjugated |
| Isotype: | IgG2a |
| Molecular weight: | 180 kDa |
| Immunogen: | Cultured T cells from an IL-2-dependent T-cell line (CA1) prepared from human peripheral blood activated with influenza virus. |
| Immunogen Uniprot ID: | P08575 |
| Myeloma used: | P3/NS1/1-Ag4.1 |
| Target background: | CD45RO (UCHL1) is also known as protein tyrosine phosphatase receptor type C (PTPRC) or leukocyte common antigen. It is a transmembrane pan-leukocyte protein with tyrosine phosphatase activity and is involved in the regulation of signal transduction in haematopoiesis and the threshold of T cell antigen receptor (TCR) signalling. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | Store at -20° C frozen. Avoid repeated freeze / thaw cycles |
| Shipping conditions: | Dry ice |
| References: |
Elgueta et al. 2019. Front Immunol. 10:981. PMID: 31118938. Moura et al. 2017. Cell Mol Immunol. 14(9):758-769. PMID: 26996067. Wu et al. 2015. Oncotarget. 6(30):28633-45. PMID: 26416419. Zlobec et al. 2013. J Transl Med. 11:104. PMID: 23627766. Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid tumor types. Dornan et al. 2002. J Biol Chem. 277(3):1912-8. PMID: 11694532. Differential association of CD45 isoforms with CD4 and CD8 regulates the actions of specific pools of p56lck tyrosine kinase in T cell antigen receptor signal transduction. Ishii et al. 2001. Proc Natl Acad Sci U S A. 98(21):12138-43. PMID: 11593028. CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. Ponsford et al. 2001. Clin Exp Immunol. 124(2):315-22. PMID: 11422210. Differential responses of CD45+ve T-cell subsets to MBP in multiple sclerosis. Smith et al. 1986. Immunology. 58(1):63-70. PMID: 2423439. Fn subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151016 | Anti-CyclinA [E72.1] |
Key Info
Anti-CyclinA [E72.1]
|
View Tool | |||||||||||||||||||
| 151021 | Anti-CyclinB1 [V152] |
Key Info
Anti-CyclinB1 [V152]
|
View Tool | |||||||||||||||||||
| 151029 | Anti-HSVICP8 [11E2] |
Key Info
Anti-HSVICP8 [11E2]
|
View Tool | |||||||||||||||||||
| 151020 | Anti-CyclinB1 [V143.1] |
Key Info
Anti-CyclinB1 [V143.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.